ARCHIVES

Bypass Budget Seeks Double Funding for Breast Cancer Research

This article is from The Cancer Letter archive.

Vol. 18 No. 43 | November 6, 1992

Download PDF Visit The Full Archive

Related Articles

PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III

November 28, 2014

NCI Cooperative Group, Cancer Center Trials Listed

April 25, 2008

FDA Approves Mylotarg For First Relapse Of Acute Myeloid Leukemia In Patients 60+.

June 2, 2000

FDA Sets High Bar for Prevention Agents as ODAC Votes Down Proscar And Avodart

December 3, 2010

Edelson To Step Down As Yale Center Director.

January 11, 2008

Panel Suggests Test Of Paid Advertising For ACS: Roundup

August 7, 1992